Mechanism of PP2A-mediated IKKβ dephosphorylation: a systems biological approach
暂无分享,去创建一个
Oliver Sawodny | Frank Allgöwer | Thomas Sauter | Johannes Witt | Sandra Barisic | Dagmar Kulms | Eva Schumann | F. Allgöwer | T. Sauter | O. Sawodny | D. Kulms | J. Witt | S. Barisic | E. Schumann
[1] Michael Karin,et al. Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .
[2] Michael Karin,et al. NF-kappaB in cancer: a marked target. , 2003, Seminars in cancer biology.
[3] Dagmar Kulms,et al. NFκB-dependent Down-regulation of Tumor Necrosis Factor Receptor-associated Proteins Contributes to Interleukin-1-mediated Enhancement of Ultraviolet B-induced Apoptosis* , 2005, Journal of Biological Chemistry.
[4] O. Sawodny,et al. Modeling of IL-1 induced NF-κB signaling and analysis of additional UVB influence , 2007, SICE Annual Conference 2007.
[5] Andre Levchenko,et al. Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses* , 2006, Journal of Biological Chemistry.
[6] Thomas A. Luger,et al. Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand- and CD95-induced Apoptosis but Not from Ultraviolet Radiation-induced Apoptosis* , 1999, The Journal of Biological Chemistry.
[7] Andre Levchenko,et al. Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. , 2006, The Journal of biological chemistry.
[8] Alexander Hoffmann,et al. Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.
[9] Michael Karin,et al. The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.
[10] S C Sun,et al. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. , 1995, The Journal of biological chemistry.
[11] Rosario Perona,et al. The role of the NFκB signalling pathway in cancer , 2008 .
[12] Céline Gélinas,et al. Rel/NF-?B and I?B factors in oncogenesis , 1997 .
[13] G P Nolan,et al. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. , 1993, Genes & development.
[14] Masao Omata,et al. Inflammation and cancer: Role of nuclear factor‐kappaB activation , 2008, Cancer science.
[15] H. Walczak,et al. Identification of PP2A as a crucial regulator of the NF-κB feedback loop: its inhibition by UVB turns NF-κB into a pro-apoptotic factor , 2008, Cell Death and Differentiation.
[16] Jens Timmer,et al. Dynamical modeling and multi-experiment fitting with PottersWheel , 2008, Bioinform..
[17] Michael Karin,et al. NF-κB in cancer: a marked target , 2003 .
[18] H. Pahl,et al. Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli. , 1995, The EMBO journal.
[19] M. Karin,et al. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. , 1999, Science.
[20] A. Ullrich,et al. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. , 1996, The EMBO journal.
[21] S J Sung,et al. Stimulation of interleukin-1 alpha and interleukin-1 beta production in human monocytes by protein phosphatase 1 and 2A inhibitors. , 1993, The Journal of biological chemistry.
[22] Rosario Perona,et al. The role of the NFkappaB signalling pathway in cancer. , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[23] Marek Kimmel,et al. Mathematical model of NF-kappaB regulatory module. , 2004, Journal of theoretical biology.
[24] Marek Kimmel,et al. Mathematical model of NF- κB regulatory module , 2004 .
[25] L. O’Neill,et al. Signal transduction pathways activated by the IL‐1 receptor family: ancient signaling machinery in mammals, insects, and plants , 1998, Journal of leukocyte biology.
[26] R. Heinrich,et al. The Regulation of Cellular Systems , 1996, Springer US.
[27] H. Shih,et al. Heptad Repeats Regulate Protein Phosphatase 2A Recruitment to I-κB Kinase γ/NF-κB Essential Modulator and Are Targeted by Human T-lymphotropic Virus Type 1 Tax* , 2007, Journal of Biological Chemistry.
[28] D. Kulms,et al. Differential effects of NF-κB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome , 2006, Oncogene.
[29] E. Harhaj,et al. Activation of NF-κB by Phosphatase Inhibitors Involves the Phosphorylation of IκBα at Phosphatase 2A-sensitive Sites (*) , 1995, The Journal of Biological Chemistry.
[30] Sankar Ghosh,et al. Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity. , 2008, The Journal of biological chemistry.
[31] Kwang-Hyun Cho,et al. The influence of the signal dynamics of activated form of IKK on NF‐κB and anti‐apoptotic gene expressions: A systems biology approach , 2006, FEBS letters.
[32] Jens Timmer,et al. Data-based identifiability analysis of non-linear dynamical models , 2007, Bioinform..
[33] H. Shih,et al. Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax. , 2007, The Journal of biological chemistry.
[34] A. Hoffmann,et al. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.
[35] C Gélinas,et al. Rel/NF-kappa B and I kappa B factors in oncogenesis. , 1997, Seminars in cancer biology.
[36] Gautam Sethi,et al. Nuclear factor-kappa B: from clone to clinic. , 2007, Current molecular medicine.
[37] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[38] Kwang-Hyun Cho,et al. Investigations into the analysis and modeling of the TNF alpha-mediated NF-kappa B-signaling pathway. , 2003, Genome research.
[39] N. Perkins,et al. Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB , 2004 .
[40] A. Krikos,et al. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. , 1992, The Journal of biological chemistry.
[41] Kwang-Hyun Cho,et al. Investigations Into the Analysis and Modeling of the TNFα-Mediated NF-κB-Signaling Pathway , 2003 .
[42] B. Aggarwal,et al. Nuclear Factor-κB Activation: From Bench to Bedside , 2008 .
[43] A. Ma,et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.
[44] Michael Karin,et al. NF-kappaB and cancer-identifying targets and mechanisms. , 2008, Current opinion in genetics & development.
[45] Gautam Sethi,et al. Nuclear factor-kappaB activation: from bench to bedside. , 2008, Experimental biology and medicine.
[46] N. Perkins,et al. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. , 2004, Molecular cell.
[47] J. Piette,et al. Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. , 1997, Journal of immunology.
[48] Miles Congreve,et al. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B , 2003, Nature.
[49] Robert S. Carter,et al. Positive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A* , 2005, Journal of Biological Chemistry.
[50] R. Page,et al. Binding, internalization, and intracellular localization of interleukin-1 beta in human diploid fibroblasts. , 1988, The Journal of biological chemistry.
[51] B. Aggarwal,et al. Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.
[52] T. Luger,et al. Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand* , 1998, The Journal of Biological Chemistry.